The expression of the miRNA-200 family in endometrial endometrioid carcinoma.
Lee
Jeong-Won
JW
Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Park
Young-Ae
YA
Choi
Jung-Joo
JJ
Lee
Yoo Young
YY
Kim
Chul-Jung
CJ
Choi
ChelHun
C
Kim
Tae-Joong
TJ
Lee
Nak Woo
NW
Kim
Byoung-Gie
BG
Bae
Duk-Soo
DS
D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000494:pharmacology; D018269:Carcinoma, Endometrioid / Q000235:genetics* / Q000378:metabolism / Q000628:therapy; D048708:Cell Growth Processes; D045744:Cell Line, Tumor; D002945:Cisplatin / Q000494:pharmacology; D003131:Combined Modality Therapy; D004357:Drug Synergism; D016889:Endometrial Neoplasms / Q000235:genetics* / Q000378:metabolism / Q000628:therapy; D005260:Female; D006801:Humans; D035683:MicroRNAs / Q000037:antagonists & inhibitors / Q000096:biosynthesis* / Q000235:genetics; D008875:Middle Aged; D058990:Molecular Targeted Therapy / Q000379:methods; D020319:Oligodeoxyribonucleotides, Antisense / Q000008:administration & dosage / Q000235:genetics; D020411:Oligonucleotide Array Sequence Analysis; D014162:Transfection; D015854:Up-Regulation
D000970:Antineoplastic Agents; C533896:MIRN200 microRNA, human; D035683:MicroRNAs; D020319:Oligodeoxyribonucleotides, Antisense; D002945:Cisplatin